Twist Bioscience Corporation TWST Income Statement
| TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | ||
|---|---|---|---|---|---|---|
| $409.48M+4.6% | $391.56M+4.0% | $376.57M+3.9% | $362.27M+4.2% | $347.68M+5.3% | ||
| $196.25M+3.6% | $189.42M+2.1% | $185.57M+0.9% | $183.88M-0.8% | $185.31M+1.3% | ||
| $213.23M+5.5% | $202.13M+5.8% | $191M+7.1% | $178.4M+9.9% | $162.37M+10.3% | ||
| 52.1%+0.4pp | 51.6%+0.9pp | 50.7%+1.5pp | 49.2%+2.5pp | 46.7%+2.1pp | ||
| $71.89M-5.5% | $76.11M-5.2% | $80.29M-4.9% | $84.41M-5.0% | $88.83M-0.3% | ||
| $272.95M+4.8% | $260.54M+5.5% | $246.98M+4.5% | $236.36M+2.9% | $229.78M+3.6% | ||
| $548.3M+4.2% | $526.07M+2.6% | $512.83M+1.6% | $504.64M-8.1% | $548.85M+1.9% | ||
| -$138.82M-3.2% | -$134.51M+1.3% | -$136.26M+4.3% | -$142.37M+29.2% | -$201.17M+3.5% | ||
| -33.9%+0.5pp | -34.4%+1.8pp | -36.2%+3.1pp | -39.3%+18.6pp | -57.9%+5.3pp | ||
| $9.21M-10.6% | $10.3M-9.4% | $11.36M-8.0% | $12.35M-7.3% | $13.32M-7.9% | ||
| —— | —— | —— | -$3.65M-24.4% | -$2.94M-7.1% | ||
| -$80.53M-6.4% | -$75.71M+1.6% | -$76.95M+9.3% | -$84.82M+55.5% | -$190.78M+3.0% | ||
| $744K-15.1% | $876K+21.7% | $720K— | —— | —— | ||
| -$81.28M-6.1% | -$76.58M+1.4% | -$77.67M+8.8% | -$85.19M+55.4% | -$191.15M+3.1% | ||
| -19.8%-0.3pp | -19.6%+1.1pp | -20.6%+2.9pp | -23.5%+31.5pp | -55%+4.8pp | ||
| -$1.33-3.9% | -$1.28+2.3% | -$1.31+9.7% | -$1.45+55.4% | -$3.25+3.8% | ||
| -$1.32-3.9% | -$1.27+2.3% | -$1.30+9.7% | -$1.44+55.7% | -$3.25+3.8% | ||
| 243.8M+0.8% | 241.7M+0.8% | 239.8M+0.8% | 238M+1.3% | 235M+0.8% | ||
| 242.6M+0.9% | 240.5M+0.8% | 238.6M+0.8% | 236.8M+0.8% | 235M+0.8% | ||
| -$81.25M-6.2% | -$76.49M+1.6% | -$77.76M+8.8% | -$85.3M+55.4% | -$191.13M+3.2% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | -$197K-166% | -$74K+14.9% | ||
| —— | —— | —— | $86K-4.4% | $90K+2,900% | ||
| —— | —— | —— | -$3.65M-24.4% | -$2.94M-7.1% | ||
| -$138.82M-3.2% | -$134.51M+1.3% | -$136.26M+4.3% | -$142.37M+29.2% | -$201.17M+3.5% | ||
| -$114.14M-3.9% | -$109.85M+1.4% | -$111.41M+4.7% | -$116.86M+32.6% | -$173.43M+3.0% | ||
| -$114.14M-3.9% | -$109.85M+1.4% | -$111.41M+4.7% | -$116.86M+32.6% | -$173.43M+3.0% | ||
| -27.9%+0.2pp | -28.1%+1.5pp | -29.6%+2.7pp | -32.3%+17.6pp | -49.9%+4.3pp | ||
| -$138.82M-3.2% | -$134.51M+1.3% | -$136.26M+4.3% | -$142.37M+29.2% | -$201.17M+3.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Twist Bioscience Corporation's revenue?
- Twist Bioscience Corporation (TWST) generated $409.5M in revenue over the trailing twelve months, up 17.8% year over year.
- Is Twist Bioscience Corporation profitable?
- Twist Bioscience Corporation is not currently profitable: it reported a net loss of $81.3M over the trailing twelve months, a -19.8% net margin.
- What are Twist Bioscience Corporation's profit margins?
- Gross margin is 52.1% and operating margin is -33.9%, with a -19.8% net margin.
- What is Twist Bioscience Corporation's earnings per share?
- Twist Bioscience Corporation's diluted EPS over the trailing twelve months is $-1.33.
- Where does Twist Bioscience Corporation's income statement data come from?
- Every line is extracted from Twist Bioscience Corporation's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
